Page last updated: 2024-09-02

s 9788 and Neoplasms

s 9788 has been researched along with Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berlion, M; Bizzari, JP; Calvo, F; Haddad, P; Lucas, C; Soudon, J	1
de Vries, EG; Hill, BT; Hosking, LK; Mulder, NH; van der Graaf, WT; Whelan, RD	1
Anstett, M; Atassi, G; Léonce, S; Pérez, V; Pierré, A; Prost, JF	1
Ardiet, C; Barbet, N; Bastian, G; Catimel, G; Clavel, M; Dumortier, A; Evene, E; Foy, M; Froudarakis, M; Grossin, F; Guastalla, JP; Lucas, C; Mazier, B; Négrier, S; Rebattu, P; Sarkany, M; Tranchand, B	1

Trials

2 trial(s) available for s 9788 and Neoplasms

Article	Year
In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:3 Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Division; Cell Line; Cell Survival; Culture Media; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Hematopoietic Stem Cells; Humans; Leukemia, T-Cell; Neoplasms; Phenotype; Piperidines; Reference Values; Triazines; Tumor Cells, Cultured; Verapamil; Vinblastine	1995
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors. Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:4 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bradycardia; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Neoplasms; Piperidines; Triazines	1998

Article

Year

In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients.

Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:3

Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Division; Cell Line; Cell Survival; Culture Media; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Hematopoietic Stem Cells; Humans; Leukemia, T-Cell; Neoplasms; Phenotype; Piperidines; Reference Values; Triazines; Tumor Cells, Cultured; Verapamil; Vinblastine

1995

Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors.

Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:4

Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bradycardia; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Neoplasms; Piperidines; Triazines

1998

Other Studies

2 other study(ies) available for s 9788 and Neoplasms

Article	Year
Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro. International journal of cancer, 1993, Sep-09, Volume: 55, Issue:2 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Membrane Glycoproteins; Molecular Structure; Neoplasms; Piperidines; Triazines; Tumor Cells, Cultured; Verapamil; Vinblastine; Vincristine	1993
[In vitro characterization of S9788, a new modulator of multidrug resistance]. Bulletin du cancer, 1993, Volume: 80, Issue:4 Topics: Animals; Antineoplastic Agents; Cell Cycle; Drug Resistance; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Mice; Neoplasms; Neoplasms, Experimental; Phenotype; Piperidines; Triazines; Tumor Cells, Cultured; Verapamil	1993

Article

Year

Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro.

International journal of cancer, 1993, Sep-09, Volume: 55, Issue:2

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Membrane Glycoproteins; Molecular Structure; Neoplasms; Piperidines; Triazines; Tumor Cells, Cultured; Verapamil; Vinblastine; Vincristine

1993

[In vitro characterization of S9788, a new modulator of multidrug resistance].

Bulletin du cancer, 1993, Volume: 80, Issue:4

Topics: Animals; Antineoplastic Agents; Cell Cycle; Drug Resistance; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Mice; Neoplasms; Neoplasms, Experimental; Phenotype; Piperidines; Triazines; Tumor Cells, Cultured; Verapamil

1993